https://www.selleckchem.com/products/h3b-120.html
UFH was significantly associated with reduced 28-day mortality (HR, 0.323, 95% CI, 0.258-0.406; p less then 0.001) and hospital mortality (HR, 0.380, 95% CI, 0.307-0.472; p less then 0.001) without increasing the risks of intracranial hemorrhage (OR, 1.480, 95% CI, 0.955-2.294; p = 0.08 or gastrointestinal bleeding (OR, 1.094, 95% CI, 0.503-2.382; p = 0.82. For subgroup analysis, it didn't change the favorable results of UFH on mortality and UFH didn't increase the risk of hemorrhage in patients with severe disease. Conclusions The